Steven Gordon, MD

Appointed
1993

Education & Fellowships

Fellowship - Emory University Hospital
Infectious Disease
Decatur, GA USA
1992

Fellowship - Centers for Disease Control, Hospital Infections Program
Epidemic Intelligence Service Officer
GA USA
1989

Residency - U.S. Public Health Service
Preventive Medicine
Atlanta, GA USA
1989

Residency - University of Chicago Hospitals
Internal Medicine
Chicago, IL USA
1987

Internship - University of Chicago Hospitals
Internal Medicine
Chicago, IL USA
1985

Medical Education - Cornell University Medical College
New York, NY USA
1984

Undergraduate - Hamilton College
Biology
Clinton, NY USA
1980

Additional Training

• Epidemic Intelligence Officer, Center for Disease Control, Division of Hospital Infections, 1987-1989
• General Preventive Medicine Epidemiology, Centers for Disease Control 1989-99

Professional Highlights

• Appointed to Defense Health Board (Federal Advisory Committee to Secretary of Defense) June 2013
  Past President , Society of Healthcare Epidemiology (January 2011)
  Past Member, Healthcare Infection Control Practices Advisory Committee, Centers for Disease Control, 2004-2008.

Certifications

• Internal Medicine - Infectious Disease
• Internal Medicine

Specialty Interests

cardiac device infections, infective endocarditis, ventricular assist device infections, mycobacterial diseases, general infectious diseases

Memberships

• Fellow, American College of Physicians
• Fellow, Infectious Disease Society of America
• Member, American Medical Association
• Member, Infectious Disease Society of Ohio
• Member, American Society of Transplantation

See publications for Steven Gordon, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/10/2024, Dr. Gordon has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.